Inove Herbaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-07-2024
- Paid Up Capital ₹ 1.00 M
as on 18-07-2024
- Company Age 25 Year, 22 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.87 Cr
as on 18-07-2024
- Satisfied Charges ₹ 2.32 Cr
as on 18-07-2024
- Revenue -88.84%
(FY 2021)
- Profit -1501.38%
(FY 2021)
- Ebitda -1977.29%
(FY 2021)
- Net Worth -1443.65%
(FY 2021)
- Total Assets -62.41%
(FY 2021)
About Inove Herbaceuticals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.87 Cr. The company has closed loans amounting to ₹2.32 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amrish Bhanushali and Nikkhil Deodar serve as directors at the Company.
- CIN/LLPIN
U24239MH1999PTC122862
- Company No.
122862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 1999
- Date of AGM
14 Mar 2022
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Vasai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Inove Herbaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amrish Bhanushali  | Director | 02-Dec-1999 | Current |
| Nikkhil Deodar | Director | 05-Aug-2008 | Current |
Financial Performance of Inove Herbaceuticals.
Inove Herbaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 88.84% decrease. The company also saw a substantial fall in profitability, with a 1501.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1443.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inove Herbaceuticals?
In 2021, Inove Herbaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Sep 2016 | ₹2.50 M | Open |
Vasai Janata Sahakari Bank Ltd. Creation Date: 20 Aug 2015 | ₹1.85 M | Open |
Others Creation Date: 20 Aug 2015 | ₹1.50 Cr | Open |
How Many Employees Work at Inove Herbaceuticals?
Unlock and access historical data on people associated with Inove Herbaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inove Herbaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inove Herbaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
